Disc Medicine Sells $720k: CFO Moves After FDA Rejection
A biotech insider trade draws attention after an FDA setback. This article unpacks the CFO's $720k stock sale at Disc...
Timing matters in budgeting. This section outlines indicators for when to revisit and tweak your budget to reflect new expenses.
18,658 articlesA biotech insider trade draws attention after an FDA setback. This article unpacks the CFO's $720k stock sale at Disc...
As March rolls in, the market keeps delivering surprises. This guide highlights two prime opportunities to buy in Mar...
NVIDIA remains dominant in AI hardware, but a software-first AI stock is delivering bigger gains. Learn why investors...
A dramatic one-month move put Rubrik in the spotlight. This article breaks down what happened, why it matters, and ho...
June brought a momentum burst in niche tech, led by space-based connectivity. This article breaks down the stock mark...
A major investment firm boosted its Dyne Therapeutics stake by nearly $4 million, highlighting renewed interest in DY...
Uber's move to back Rivian could reshape both companies' futures and the EV/autonomy landscape. This guide breaks dow...
As TJX prepares for the (tjx) 2027 earnings call, investors are weighing store growth, margins, and online evolution....
A dramatic May surge can lure investors, but this glorious growth stock may face headwinds in June. This guide explai...
Johnson Johnson walking away from a GLP-1 obesity obsession signals a shift to a diversified, potentially more resili...
A deep dive into MiB: Bill Gurley, Benchmark—how a pioneering VC built a team culture, backed Uber and other giants, ...
Two quantum computing stocks with upside projections have caught the eye of Wall Street. This guide breaks down why t...